Female fertility after cytotoxic therapy-protection of ovarian function during chemotherapy of malignant and nonmalignant diseases

European Journal of Haematology

Volumn 75, Issue SUPPL.66, 2004, Pages 77-82

  Mattle, Verena ^a   Behringer, Karolin ^b   Engert, Andreas ^b   Wildt, Ludwig ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b UNIVERSITY OF COLOGNE   (Germany)

Author keywords

Chemotherapy; Cryo preservation; Cytotoxic drugs; Fertility; Gnrh analogue; Ovarian failure; Ovarian protection; Sex steroids

Indexed keywords

EID: 84900414345     PISSN: 09024441     EISSN: 16000609     Source Type: Journal    
DOI: 10.1111/j.1600-0609.2005.00459.x     Document Type: Article

References (26)

1. Blumenfeld Z, Dann E, Avivi I, Epelbaum R, Rowe JM. Fertility after treatment for Hodgkin's disease. Ann Oncol 2002;13(Suppl. 1):138-147.
2. Howell SJ, Shalet SM. Pharmacological protection of the gonads. Med Pediatr Oncol 1999;33:41-45.
3. Block E. Quantitative morphological investigations of the follicular system in women. Acta Endocrinologica 1951; 8:33.
4. Block E. Quantitative investigations of the follicular system of women. Variations at different ages. Acta Anatomica 1952;14:108-123.
5. Siebzehnruebl E, Kohl J, Dittrich R, Wildt L. Freezing of human ovarian tissue-not the oocytes but the granulosa is the problem. Mol Cell Endocrinol 2000;169:109-111.
6. Hillier SG, Zeleznik AJ, Knazek RA, Ross GT. Hormonal regulation of preovulatory follicle maturation in the rat. J Reprod Fertil 1980;60:219-229.
7. Zeleznik AJ. Follicle selection in primates: "many are called but few are chosen". Biol Reprod 2001;65:655-659.
8. Bittl A, Beck E, Jäger W, Wildt L. Untersuchungen zur Amenorrhoe unter adjuvanter CMF-Chemotherapie bei Mammakarzinom-Patientinnen. In: Lang N, Jäger W, eds. Zytostatikabedingte Nebenwirkungen. München: Zuckschwerdt Verlag, 1993:14-20.
9. Franchi-Rezgui P, Rousselot P, Espie M, Brier J, Pierre Marolleau J, Gisselbrecht C, Brice P. Fertility in young women after chemotherapy with alkylating agents for Hodgkin-and non-Hodgkin lymphomas. Hematol J 2003;4:116-120.
10. Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG. The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 1983;52:988-993.
11. Gradishar WJ, Schilsky RL. Ovarian function following radiation and chemotherapy for cancer. Semin Oncol 1989;16:425-436.
12. Myers SE, Schilsky RL. Prospects for fertility after cancer chemotherapy. Semin Oncol 1992;19:597-604.
13. Kreuser ED, Felsenberg D, Behles C, Seibt Jung H, Mielcarek M, Diehl V, Dahmen E, Thiel E. Long-term gonadal dysfunction and its impact on bone mineralization in patients following COPP/ABVD chemotherapy for Hodgkin's disease. Ann Oncol 1992;3(Suppl. 4):105-110.
14. Behringer K, Breuer K, Reineke T, May M, Nogova L, Klimm B, Schmitz T, Wildt L, Diehl V, Engert A. Secondary amenorrhea after Hodgkin lymphoma is influenced by age at treatment, stage of disease, chemotherapy regime and the use of oral contraceptives during therapy: a report from the German Hodgkin Lymphoma Study Group (GHSG). J Clin Oncol 2005 (In press).
15. Blumenfeld Z, Avivi I. Trying to preserve ovarian function in the face of chemotherapy?. Fertil Steril 1999;71:773-775.
16. Blumenfeld Z. Ovarian rescue/protection from chemotherapeutic agents. J Soc Gynecol Investig 2001;8:S60-S64.
17. Blumenfeld Z. Preservation of fertility and ovarian function and minimalization of chemotherapy associated gonadotoxicity and premature ovarian failure: the role of inhibin-A and-B as markers. Mol Cell Endocrinol 2002;187:93-105.
18. Chapman RM, Sutcliffe SB. Protection of ovarian function by oral contraceptives in women receiving chemotherapy for Hodgkin's disease. Blood 1981;58:849-851.
19. Donnez J, Dolmans MM, Demylle D, Jadoul P, Pirard C, Squifflet J, Martinez-Madrid B, Van Langendonckt A. Live birth after orthotopic transplantation of cryopreserved ovarian tissue. Lancet 2004;364:1405-1410.
20. Shaw JM, Bowles J, Koopman P, Wood EC, Trounson AO. Fresh and cryopreserved ovarian tissue samples from donors with lymphoma transmit the cancer to graft recipients. Hum Reprod 1996;11:1668-1673.
21. Parrott DMV. The fertility of mice with orthotopic ovarian grafts derived from frozen tissue. J Reprod Fertil 1954;1:230-241.
22. Familiari G, Caggiati A, Nottola SA, Ermini M, Di Benedetto MR, Motta PM. Ultrastructure of human ovarian primordial follicles after combination chemotherapy for Hodgkin's disease. Hum Reprod 1993;8:2080-2087.
23. Morice P, Castaigne D, Haie-Meder C, Pautier P, El Hassan J, Duvillard P, Gerbaulet A, Michel G. Laparoscopic ovarian transposition for pelvic malignancies: indications and functional outcomes. Fertil Steril 1998;70:956-960.
24. HovattaO, SilyeR, KrauszT, AbirR,MargaraR, Trew G, Lass A, Winston RM. Cryopreservation of human ovarian tissue using DMSO and propanediol-sucrose as cryoprotectants. Hum Reprod 1996;11:1268-1272.
25. Oktay K, Newton H, Gosden RG. Transplantation of cryopreserved human ovarian tissue results in follicle growth initiation in SCID mice. Fertil Steril 2000;73:599-603.
26. Oktay K, Bujuk E, Veeck L, Zaninovic N, Xu K, Takeuchi T, Opsahl M, Rosenwaks Z. Embryo development after heterotpic transplantation of cryopreserved ovarian tissue. Lancet 2004;363:837-840.